Salix Pharmaceuticals, Ltd. · Morrisville, NC United States (NASDAQ: SLXP)
| 1700 Perimeter Park Dr. | Phone: 919-862-1000 |
| Morrisville, NC | Fax: 919-862-1095 |
| 27560 | |
| United States |
Salix Pharmaceuticals, Ltd. Rankings
| S&P 600 |
Company Description
Salix Pharmaceuticals is a finishing school for drugs. With a focus on treating gastrointestinal ailments, the company prefers to acquire drug candidates nearing commercial viability. It then takes them through the final development stages and brings them to market. The company's marketed products include Apriso and Colazal (for ulcerative colitis), Pepcid (gastric ulcers and acid reflux), and Xifaxan (an antibiotic for travelers' diarrhea and liver troubles). Other products include colonoscopy preparatory bowel purgatives MoviPrep, OsmoPrep, and Visicol. Its late-stage candidates include both new drugs and new uses for existing drugs. Salix's sales and marketing team primarily targets US gastroenterologists.
Financials
| Company Type | Public - NASDAQ: SLXP Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 390 |
Executives
25 executives listed for Salix Pharmaceuticals, Ltd.'s Morrisville, NC location.
| Chairman | Thomas D'Alonzo | |
|---|---|---|
| President, CEO, and Director | Carolyn Logan | |
| EVP Finance and Administration and CFO | Adam Derbyshire |


